Fundraising Fox

Rick Xu

Investor

Venture Partner at Quan Capital

About

Dr. Rick Xu is a Venture Partner at Quan Capital, which he joined in 2021, and has advised and acted as interim CMO for several of the firm's portfolio companies. He currently serves as Chief Medical Officer of Oricell Therapeutics and was previously the founding Chief Medical Officer of InnoCare Pharma (HKEX: 09969), with roughly 30 years in global clinical development at Roche/Genentech, Pfizer, and Sterling Winthrop. He earned his medical degree from Harbin Medical University, completed a Gastroenterology fellowship at Truman Medical Center, and holds a Ph.D. in Biopharmaceuticals from SUNY at Buffalo.

Invests in

Biotech

Colleagues at Quan Capital

Frequently asked questions

Who is Rick Xu?
Dr. Rick Xu is a Venture Partner at Quan Capital, which he joined in 2021, and has advised and acted as interim CMO for several of the firm's portfolio companies. He currently serves as Chief Medical Officer of Oricell Therapeutics and was previously the founding Chief Medical Officer of InnoCare Pharma (HKEX: 09969), with roughly 30 years in global clinical development at Roche/Genentech, Pfizer, and Sterling Winthrop. He earned his medical degree from Harbin Medical University, completed a Gastroenterology fellowship at Truman Medical Center, and holds a Ph.D. in Biopharmaceuticals from SUNY at Buffalo.
Where does Rick Xu work?
Rick Xu is Venture Partner at Quan Capital.
What does Rick Xu invest in?
Rick Xu invests in Biotech.